Aspirin in prevention of ovarian cancer: are we at the tipping point?

Experimental, epidemiological, and clinical data over the last two decades have supported the hypothesis that aspirin and nonsteroi-dal anti-inflammatory drugs (NSAIDs) possess anticancer properties. Experimental data suggest induction of apoptosis, inhibition of angiogenesis, and enhanced cellular immune responses as possible mechanisms (1… CONTINUE READING